Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1995 1
2000 1
2001 1
2007 1
2008 1
2009 2
2010 4
2011 7
2012 2
2013 2
2014 4
2015 5
2016 8
2017 6
2018 7
2019 8
2020 5
2021 14
2022 7
2023 12
2024 8
2025 9
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
Müller J, Sharmin S, Lorscheider J, Ozakbas S, Karabudak R, Horakova D, Weinstock-Guttman B, Shaygannejad V, Etemadifar M, Alroughani R, Patti F, Eichau S, Prat A, Lugaresi A, Tomassini V, Kermode AG, Amato MP, Turkoglu R, Altintas A, Buzzard K, Soysal A, van der Walt A, Butzkueven H, Blanco Y, Gerlach O, Khoury SJ, Barnett M, John N, Lechner-Scott J, Foschi M, Surcinelli A, van Pesch V, Prevost J, Sa MJ, Maimone D, D'hooghe M, Hughes S, Hodgkinson S, McGuigan C, Cartechini E, Taylor B, Spitaleri D, Slee M, McCombe P, Yamout B, Benkert P, Kuhle J, Kappos L, Roos I, Kalincik T; MSBase Study Group; Havrdova EK, Girard M, Duquette P, Fabis-Pedrini M, Carroll WM, Skibina O, Gouider R, Mrabet S, Ramo-Tello C, Solaro C, Habek M, Van Wijmeersch B, Ampapa R, Macdonell R, Oreja-Guevara C, de Gans K, Laureys G, Oh J, Garber J, Gray O, Agüera-Morales E, Sanchez-Menoyo JL, Castillo-Triviño T, Grigoriadis N, Petersen T, Hardy TA, Vucic S, Reddel S, Ramanathan S, Al-Asmi A, Simu M, Baghbanian SM, Poehlau D, Al-Harbi T, Rojas JI, Deri N, Lalive P, Cambron M, Csepany T, Shuey N, Willekens B, Shaw C, Decoo D, Massey J, Yaldizli Ö, Derfuss T, Granziera C. Müller J, et al. Among authors: ramo tello c. JAMA Neurol. 2025 Jun 1;82(6):614-625. doi: 10.1001/jamaneurol.2025.0495. JAMA Neurol. 2025. PMID: 40227706 Free PMC article.
Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis.
Fondelli F, Willemyns J, Domenech-Garcia R, Mansilla MJ, Godoy-Tena G, Ferreté-Bonastre AG, Agúndez-Moreno A, Presas-Rodriguez S, Ramo-Tello C, Ballestar E, Martínez-Cáceres E. Fondelli F, et al. Among authors: ramo tello c. J Clin Invest. 2024 Nov 1;134(21):e178949. doi: 10.1172/JCI178949. J Clin Invest. 2024. PMID: 39287981 Free PMC article.
Catastrophic demyelinating multifocal encephalitis.
Rubio-Guerra S, Massuet-Vilamajó A, Presas-Rodríguez S, Ramo-Tello C. Rubio-Guerra S, et al. Among authors: ramo tello c. Neurologia (Engl Ed). 2022 Mar;37(2):159-163. doi: 10.1016/j.nrl.2021.03.001. Epub 2021 Apr 7. Neurologia (Engl Ed). 2022. PMID: 33838947 Free article. English, Spanish. No abstract available.
Catastrophic demyelinating multifocal encephalitis.
Rubio-Guerra S, Massuet-Vilamajó A, Presas-Rodríguez S, Ramo-Tello C. Rubio-Guerra S, et al. Among authors: ramo tello c. Neurologia (Engl Ed). 2022 Mar;37(2):159-163. doi: 10.1016/j.nrleng.2021.12.001. Epub 2021 Dec 21. Neurologia (Engl Ed). 2022. PMID: 34952830 Free article. No abstract available.
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.
Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari CG, Lo Fermo S, Prat A, Girard M, Duquette P, Izquierdo G, Eichau S, Grammond P, Boz C, Kalincik T, Blanco Y, Buzzard K, Skibina O, Sa MJ, van der Walt A, Butzkueven H, Terzi M, Gerlach O, Grand'Maison F, Foschi M, Surcinelli A, Barnett M, Lugaresi A, Onofrj M, Yamout B, Khoury SJ, Prevost J, Lechner-Scott J, Maimone D, Amato MP, Spitaleri D, Van Pesch V, Macdonell R, Cartechini E, de Gans K, Slee M, Castillo-Triviño T, Soysal A, Sanchez-Menoyo JL, Laureys G, Van Hijfte L, McCombe P, Altintas A, Weinstock-Guttman B, Aguera-Morales E, Etemadifar M, Ramo-Tello C, John N, Turkoglu R, Hodgkinson S, Besora S, Van Wijmeersch B, Fernandez-Bolaños R, Patti F; MSBase Study Group. Toscano S, et al. Among authors: ramo tello c. Neurotherapeutics. 2025 Mar;22(2):e00552. doi: 10.1016/j.neurot.2025.e00552. Epub 2025 Feb 17. Neurotherapeutics. 2025. PMID: 39965993 Free PMC article.
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.
Roos I, Sharmin S, Malpas C, Ozakbas S, Lechner-Scott J, Hodgkinson S, Alroughani R, Eichau Madueño S, Boz C, van der Walt A, Butzkueven H, Buzzard K, Skibina O, Foschi M, Grand'Maison F, John N, Grammond P, Terzi M, Prévost J, Barnett M, Laureys G, Van Hijfte L, Luis Sanchez-Menoyo J, Blanco Y, Oh J, McCombe P, Ramo Tello C, Soysal A, Prat A, Duquette P, Yamout BI, Khoury S, van Pesch V, Macdonell R, José Sá M, Slee M, Kuhle J, Maimone D, Spitaleri D, Willekens B, Asmi AA, Tallantyre E, Robertson NP, Coles A, L Brown JW, Kalincik T. Roos I, et al. Among authors: ramo tello c. Mult Scler. 2024 Aug;30(9):1163-1175. doi: 10.1177/13524585241267211. Epub 2024 Aug 1. Mult Scler. 2024. PMID: 39087208
Persistent progression independent of relapse activity in multiple sclerosis.
Zhu C, Zhou Z, Kalincik T, Roos I, Buzzard K, Skibina O, Alroughani R, Kuhle J, Girard M, Grammond P, Lechner-Scott J, Gerlach O, John N, McCombe P, Macdonell R, van Pesch V, Laureys G, Prevost J, Horakova D, Kubala Havrdova E, Castillo-Triviño T, Ramo-Tello C, Blanco Y, Meca-Lallana JE, Lugaresi A, Tomassini V, Cartechini E, Amato MP, Spitaleri D, Patti F, Maimone D, Foschi M, Surcinelli A, D'Amico E, Yamout B, Khoury SJ, Jose Sa M, Boz C, Ozakbas S, Weinstock-Guttman B, Merlo D, Monif M, Jokubaitis VG, van der Walt A, Butzkueven H. Zhu C, et al. Among authors: ramo tello c. Brain Commun. 2025 Aug 21;7(5):fcaf306. doi: 10.1093/braincomms/fcaf306. eCollection 2025. Brain Commun. 2025. PMID: 40909095 Free PMC article.
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years.
Roberts JI, Sharmin S, Horakova D, Kubala Havrdova E, Ozakbas S, Lugaresi A, Tomassini V, Alroughani R, Buzzard K, Skibina O, Boz C, Turkoglu R, Maimone D, Yamout B, Khoury SJ, Spitaleri D, Lechner-Scott J, Girard M, Duquette P, Al-Asmi A, Ampapa R, Foschi M, Surcinelli A, Patti F, Van Pesch V, Ramo-Tello C, Sánchez-Menoyo JL, Altintas A, Grammond P, Cartechini E, Csepany T, Laureys G, Willekens B, Roos I, Kalincik T, Study Group M. Roberts JI, et al. Among authors: ramo tello c. J Neurol Neurosurg Psychiatry. 2025 Nov 13;96(12):1185-1193. doi: 10.1136/jnnp-2025-336343. J Neurol Neurosurg Psychiatry. 2025. PMID: 40721309
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study.
Siriratnam P, Huda S, Van der Walt A, Sanfilippo P, Sharmin S, Foong YC, Yeh WZ, Zhu C, Khoury SJ, Csepany T, Willekens B, Etemadifar M, Ozakbas S, Nytrova P, Altintas A, Al-Asmi A, Ramo-Tello C, Laureys G, Patti F, Horakova D, Foschi M, Boz C, McCombe P, Turkoglu R, Roos I, Lechner-Scott J, Kalincik T, Jokubaitis V, Butzkueven H, Monif M. Siriratnam P, et al. Among authors: ramo tello c. J Neurol. 2025 Apr 14;272(5):339. doi: 10.1007/s00415-025-13064-6. J Neurol. 2025. PMID: 40227344 Free PMC article.
97 results